ArticleJournal for immunotherapy of cancer2026
Commentary on "Comparative efficacy and safety of PSCA CAR-engineered Vδ1 γδ T cells for immunotherapy of pancreatic cancer".
Dorine A de Bont et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.